Eli Lilly

Johnson & Johnson

McKesson

Bristol-Myers

AbbVie

CoreSite Realty

Merck

Zoetis

Pfizer

Viatris

VanEck Vectors Pharmaceutical ETF

PPH tracks a market-cap-weighted index of 25 of the largest global pharmaceutical firms.

Virtus LifeSci Biotech Clinical Trials ETF

VanEck Vectors Biotech ETF

Virtus LifeSci Biotech Products ETF

Loncar Cancer Immunotherapy ETF

First Trust NYSE Arca Biotechnology Index Fund

First Trust Nasdaq Pharmaceuticals ETF 

Amplify Treatments Testing & Advancements ETF

Global X Genomics & Biotechnology ETF

abrdn Life Sciences Investors 

iShares Nasdaq Biotechnology ETF

Defiance Nasdaq Junior Biotechnology ETF

iShares U.S. Pharmaceuticals ETF

Direxion Daily S&P Biotech Bear 3X Shares

Direxion Daily S&P Biotech Bull 3X Shares

Invesco Dynamic Biotechnology & Genome ETF

Direxion Daily Pharmaceutical & Medical Bull 3X Shares

Invesco Dynamic Pharmaceuticals ETF

SPDR S&P Biotech ETF

SPDR S&P Pharmaceuticals ETF

Just over one year after COVID-19 disrupted our lives, we are now getting to the point where multiple vaccine options are nearly ubiquitous for those in the United States. Per the CDC, as of April 12, 36% of the entire US population has received at least one vaccine, and 79% of those aged 65 years and older.

Moving Beyond COVID In Biopharma

iBio

Moderna

Novavax

Ocugen, Inc.

Sorrento Therapeutics Inc

AstraZeneca

Pharmaceutical stocks gained a lot from the pandemic and the race to vaccines, but most of that upside is off the table now. The post 7 Pharmaceutical Stocks That Could Get a Covid Hangover appeared first on InvestorPlace.

7 Pharmaceutical Stocks That Could Get a Covid Hangover

Coming off a vaccine rally that started in the middle of 2020, the pharmaceutical industry will continue to evolve as technological advances make their way into the sector, which should help ETFs like the VanEck Vectors Pharmaceutical ETF (PPH). PPH seeks to replicate as closely as possible the price and yield performance of the MVIS® [.

Pharma Goes Beyond the Vaccine. ‘PPH' on the Verge of More Advances

Principal Healthcare Innovators Index ETF

Direxion Daily Healthcare Bull 3x Shares

Fidelity MSCI Health Care ETF

First Trust Health Care AlphaDEX Fund

abrdn Healthcare Investors 

iShares U.S. Healthcare ETF

John Hancock Multifactor Healthcare ETF

LeMaitre Vascular

Global X Longevity Thematic ETF

ProShares UltraShort Health Care

ProShares Ultra Health Care

Invesco S&P 500 Equal Weight Health Care ETF

Vanguard Health Care ETF

Pacer BioThreat ETF

Health Care Select Sector SPDR Fund

The advantage for dividend investors in this sector is the wide choice of large and well-established companies. AbbVie is a drug company with strong exposure to the immunology and the oncology markets.

Healthcare: A Wide Choice Of Large And Well-Established Companies

Healthcare Q4 results seem robust given that it is the fourth-best sector from a revenue growth look and the sixth-strongest in terms of earnings growth.

Pharma ETFs in Focus Post Q4 Earnings

AstraZeneca has agreed to buy rare-disease specialist Alexion Pharmaceuticals for $39 billion. The deal would represent the biggest transaction in pharmaceuticals since 2019.

ETFs to Tap AstraZeneca Mega-Deal to Buy Alexion

With 2020 election season in the rearview mirror, it could be a great time to revisit health and pharmaceutical ETFs, including the VanEck Vectors Pharmaceutical ETF (NASDAQ: PPH). PPH tracks the MVIS US Listed Pharmaceutical 25 Index.

Beyond the Vaccine: The Long Runway for Health and Pharmaceutical ETFs

After scuffling amid political uncertainty leading up to Election Day, pharmaceutical stocks and exchange-traded funds are finally perking amid a spate of encouraging news regarding coronavirus vaccine progress. What Happened: The VanEck Vectors Pharmaceutical ETF (NASDAQ: PPH), which tracks the US Listed Pharmaceutical 25 Index, is a prime example of recent pharmaceutical equity ebullience.

Write A Prescription For This Pharma ETF

By VanEck Hope Springs Eternal Hopes of a return to normality are increasing after a year of pandemic-induced tumult. News that COVID-19 vaccines developed by Pfizer and BioNTech, and Moderna were more than 90% effective in clinical trials lifted global stock markets, with health care stocks outpacing the gains in the U.S., Asia and Europe [.

Pharma Sector Steps up as a Portfolio Prescription

Invesco S&P SmallCap Health Care ETF

SPDR S&P Health Care Services ETF

The broader medical sector should be in the spotlight now on hopes of a coronavirus vaccine and the likelihood of a divided congress.

3 Reasons to Bet on Healthcare ETFs

Easing worries regarding major policy changes are driving the relief rally in the healthcare and biotech spaces in the post-election period.

Here's Why Healthcare ETFs Are Rallying Post Elections

The slew of Q3 results have led to mixed trading in pharma ETFs over the past month.

Q3 Earnings Fail to Impress Pharma ETFs

PetMed Express

These trio of pets stocks to buy offers global potential for investors looking to play the growing trend of owning a furry friend.
The post 3 Pet Stocks to Buy for Your Furry Friend appeared first on InvestorPlace.

3 Pet Stocks to Buy for Your Furry Friend

Investors looking for compelling valuations don’t have to go deep into the lagging value factor. They can harness some growth with pharmaceuticals ETFs, including the VanEck Vectors Pharmaceutical ETF (NASDAQ: PPH).

Some Good Deals Are Available in Pharmaceuticals ETFs

For the first four months of the market’s cornavirus recovery, one of the key themes was the dominance of biotech.

A Divergence Has Occurred In Healthcare

Total earnings of 66.4% of the healthcare market capitalization that has reported so far are up 4.4% on revenue growth of 4%.

Pharma ETFs Soar on Robust Q2 Earnings

Renaissance IPO ETF

Invesco DWA Healthcare Momentum ETF

Vaxart

There are at least a hundred candidates in the COVID-19 vaccine race globally. However, few companies like Moderna, Pfizer and AstraZeneca are showing considerable hope.

COVID-19 Vaccine Push Brings Hope: Stock & ETF Beneficiaries

The VanEck Vectors Pharmaceutical ETF (NASDAQ: PPH) is among the healthcare ETFs recently showing signs of life due in large part to the fight against the coronavirus and although this is an election year, there could be more upside to come for PPH and friends. PPH tracks the MVIS US Listed Pharmaceutical 25 Index.

Assessing Political Outcomes for Pharmaceuticals ETFs

Several companies sit at the forefront of developing a coronavirus vaccine. Gain exposure to each using the following three ETFs.

3 ETFs in Focus as Race for Vaccine Intensifies

KraneShares MSCI All China Health Care Index ETF

The best pharmaceutical ETFs for Q3 2020 are KURE, XPH, and PPH.

Best Performing Pharmaceutical ETFs for Q3 2020

ProShares S&P 500 Dividend Aristocrats ETF

Vanguard Value ETF

With Economic Impact Payments beginning to arrive, it's time to put your money to work.

The Best ETFs to Buy With Your $1,200 Stimulus Check

The pharmaceutical industry is often a hotbed of takeover rumors.

Expect Pharmaceuticals M&A Activity to Rebound After COVID-19 Eases

Allergan

ARMOUR Residential REIT

Mr. Cooper Group Inc

iShares U.S. Home Construction ETF

VanEck Mortgage REIT Income ETF

TRI Pointe Group

Financial Select Sector SPDR Fund

Given recovering fundamentals, investors should take advantage of the beaten-down prices. For them, we have highlighted four solid ETF & stock picks each from the industries that are currently undervalued and have a solid Zacks Rank.

News for VanEck Vectors Pharmaceutical ETF ETF (PPH)